NCT02639663

Brief Summary

Leboride is a dental support device that was developed for reducing pain during active labor. It is made of an inert material, placed in the woman's mouth and does not disturb breathing, talking, or any other activity expected during labor. It is a single-use device, each user receives a new one. This study hypothesis is that the Leboride use can reduce pain during breastfeeding, by that improve women's breastfeeding experience, and increase breastfeeding rates.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
700

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Jan 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 24, 2015

Completed
8 days until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

December 24, 2015

Status Verified

December 1, 2015

Enrollment Period

1 year

First QC Date

December 21, 2015

Last Update Submit

December 21, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of change in of the vas scores before and after using this device

    24 months

Secondary Outcomes (2)

  • Duration of breastfeeding

    24 months

  • The rate of cessation of breastfeeding because of pain

    24 months

Study Arms (2)

women whom are interested in breastfeeding and have not begun.

EXPERIMENTAL

Post-partum primi and multiparous women Post-partum primipara and multiparous women whom are interested in breastfeeding and have not begun yet. This arm will be randomized into 2 groups 1. Intervention group: participants will receive the dental device and be instructed to use it during breastfeeding. 2. Control group: participants will not receive any device for breastfeeding pain control

Device: dental device

Post-partum women that have already begun breast feeding

EXPERIMENTAL

2\. Post-partum women that have already begun breast feeding, will receive the dental device and each woman will be serve as her own control (breastfeeding before and after the use of the dental device.

Device: dental device

Interventions

Leboride 1. Post-partum primi and multiparous women whom are interested in breastfeeding and have not begun yet. This arm will be randomized into 2 groups 1. Intervention group: participants will receive the dental device and be instructed to use it during breastfeeding. 2. Control group: participants will not receive any device for breastfeeding pain control 2. Post-partum women that have already begun breast feeding, will receive the dental device and each woman will be serve as her own control (breastfeeding before and after the use of the dental device.

Post-partum women that have already begun breast feedingwomen whom are interested in breastfeeding and have not begun.

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Maternal age 18-45 years. Normal vital signs.

You may not qualify if:

  • Contraindications for breastfeeding. Significant systemic disease that cause pain or require chronic pain relief.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Breast Feeding

Interventions

Occlusal Splints

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Intervention Hierarchy (Ancestors)

Orthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and Supplies

Study Officials

  • Ariel many, professor

    Tel Aviv Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ariel many, professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2015

First Posted

December 24, 2015

Study Start

January 1, 2016

Primary Completion

January 1, 2017

Study Completion

January 1, 2018

Last Updated

December 24, 2015

Record last verified: 2015-12

Data Sharing

IPD Sharing
Will not share